Lab Overview

The McDevitt lab is focused on the engineering of innovative technologies to translate the morphogenic potential of stem cells as models of development and disease, as well to develop cellular and molecular therapies aimed to treat degenerative diseases and traumatic injuries. Learn more about the research.

Since stem cells are promising for a number of applications, the emphasis of the McDevitt Lab is on the development of technology platforms to advance therapies that span multiple diseases.

Our technologies are applicable to a wide variety of diseases, including cardiovascular, orthopedic and neurological disorders. Specific diseases that we can apply our research to include treatments for diabetes, chronic wounds, aging, arthritis and other autoimmune disorders. The McDevitt lab's work also has other applications, including wound healing, irritable bowel syndrome, epilepsy and bone regeneration to name just a few. Click here for a complete list of research and disease applications.

Videos

  • Overview of Stem Cell Engineering
  • Todd was 1 of 6 panelists that toured Europe and Asia to do an international assessment of the Stem Cell Engineering field.

News

 
Ken Nakamura and Todd McDevitt will study how to boost cells’ energy and how the strategy can best treat disease
 
Interview regarding recent COVID research on human cardiac cells and tissues.
 
McDevitt lab COVID-19 cardiac explained by live science.
 
A growing number of studies are raising concerns about the coronavirus’ long-term effects on the heart. Athletes especially need to heed the warnings.
 
Evidence has emerged of severe direct viral assault on the heart muscle.
 
Recent research suggests some people who recovered might have lingering heart inflammation and injury, even if their cases weren’t severe.